40+ results for "Manufacturing"
HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors
Communication with FDA at recent Type B meeting provided clear guidance for next steps to prepare IND application to support first-in-human clinical study in cancer HCW11-018b is Company’s lead candidate in its second-generation T-Cell Engager Program constructed using proprietary non-FC based TRBC platform technology Manufacturing of cGMP material for clinical trials is underway IND application remains on track to be filed in 1H 2027 MIRAMAR, Fla., Oct. 09, 2026 (GLOBE NEWSWIRE) -- HCW Biologic
MIDEA COMPLETES THE ACQUISITION OF ESAOTE
Midea Group marks its commitment to healthcare and innovation by completing the acquisition of Esaote GENOA, Italy , Oct. 9, 2026 -- Esaote S.p.A., a leader in the medical imaging sector, announces the completion of the controlling stake acquisition of its share capital by Midea the Chinese global technology group headquartered in the district of Shunde, Foshan. The transaction is aimed at fostering synergies between Esaote and Midea s Healthcare Division to increase international competitiveness. Esaote will be part of Midea Healthcare and will continue to operate as an independent global medical equipment company, headquartered in Genoa, Italy, with R&D and manufacturing facilities in Italy and the Netherlands.
Ritedose Opens Advanced Laboratory and Expands Analytical Capabilities to Accelerate Pharmaceutical Innovation—Positioning the Company as a Preferred Partner for Drug Development and Manufacturing
Triples laboratory footprint with the $17 million investment. Features new leachables and extractables testing capabilities. Allows for seamless development and manufacturing experience while supporting pharmaceutical products throughout entire lifecycle. Creates an integrated laboratory infrastructure coupled with the Company’s microbiology laboratory expansion. COLUMBIA, S.C., Oct. 08, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation announced the opening of its new state-of-the-art current G
Bio Usawa Takes Major Step Toward Building a Self-Sustaining Biotechnology Ecosystem in Africa
The establishment of Botswana subsidiary strengthens regional capacity and expands access to affordable biologics SAN FRANCISCO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology today announced the launch of Bio Usawa Biotech Botswana (Pty) Ltd, marking an important milestone in the company’s mission to build a self-sustaining biotechnology ecosystem across Africa and expand access to safe, effective, and affordable biologic medicines. The Botswana subsidiary expands Bio Usawa’s interna
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
Alvotech and LOTTE Biologics signing ceremony Alvotech and LOTTE Biologics signing ceremony to commemorate the formation of a strategic manufacturing agreement on October 6, 2026 Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics’ Syracuse facility in New York Strategic long-term partnership to increase Alvotech’s global manufacturing capacity and support growth in demand REYKJAVIK, Iceland, and SEOUL, South Korea, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech (
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics’ Syracuse facility in New York Strategic long-term partnership to increase Alvotech’s global manufacturing capacity and support growth in demand REYKJAVIK, Iceland, and SEOUL, South Korea (October 6, 2026) - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and LOTTE Biologics, a contract developmen
Applied Biologics Announces Manufacturing Milestone in APPB-515 Osteoarthritis Gene Therapy Program
Successful production of reference protein advances proprietary protein engineering and gene therapy development program SCOTTSDALE, Ariz., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, LLC today announced the successful manufacture of the first recombinant reference protein for APPB-515, the Company’s investigational gene therapy program for osteoarthritis. The milestone establishes important manufacturing capabilities for the program and enables Applied Biologics to advance the next sta
Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
Company advances manufacturing scale-up, regulatory testing and preclinical work supporting its planned FDA 510(k) submission in the first quarter of 2027. Multiple scaled-up batches of CXU™ material met predefined specifications, supporting both regulatory testing and future commercial production. RENO, Nev., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage medical device and regenerative medicine company advancing CXU ™, a
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
SQC s quantum-enhanced AI chip Watermelon recognized for its ability to make classical models faster, more efficient and less resource-intensive SYDNEY , Oct. 6, 2026 -- Silicon Quantum Computing (SQC), a pioneer in quantum computing and atomic-precision manufacturing, today announced that its quantum-enhanced AI system, Watermelon , has been named to Fast Company s 2026 Next Big Things in Tech list. The annual list recognizes breakthrough technologies with the potential to transform industries and shape the future.
30 Investors, Founders and Policymakers join DeepVerse, Startup Policy Forum's Centre for DeepTech Innovation
Startup Policy Forum (SPF) launches DeepVerse, its Centre for DeepTech Innovation, a multi-stakeholder platform to accelerate India s deeptech ecosystem The platform features an 18-member high-powered Advisory Board comprising investors, founders, global technology firms, policymakers, government, and academia Ten leading VC firms come together on the platform to promote India s deeptech ecosystem including Accel India, Lightspeed, Bessemer Venture Partners, Speciale Invest, Endiya Partners, Crane Ventures, Avaana Capital, Iron Pillar, Stride Asset Management and Beenext. The Centre will focus on ten deeptech sub-sectors, including semiconductors, advanced manufacturing, spacetech, quantum tech, defence tech, biotech & healthtech, cleantech & energy, drones & aerospace, electric vehicles, robotics. DeepVerse builds on 100DesiDeepTechs, SPF s national initiative with MeitY Startup Hub (MSH), Startup India (DPIIT) and IIT Madras, which identified a cohort of India s 100 leading deeptech startups in May 2026. DeepVerse will soon launch its extensive report to highlight policy actionables across the ten sectors
Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility
The new microbiology laboratory and sterility testing suite are designed for GMP drug product applications. This addition is part of the broader Lexington expansion and includes a dedicated sterility testing isolator, three new biosafety cabinets, and enhanced laboratory capacity. The remainder of the expansion, including commercial-scale fill/finish, is expected to be online in late 2027. MUMBAI, India , Oct. 6, 2026 -- Piramal Pharma Solutions ( PPS ), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. ( PPL ) (NSE: PPLPHARMA) (BSE: 543635), has opened a new microbiology laboratory at its sterile injectable facility in Lexington, Kentucky. This addition marks a significant step forward in PPS ongoing 85 million Lexington expansion, aimed at enhancing commercial-scale capabilities and improving operational efficiency. The new laboratory was released for routine GMP use on September 11, 2026, and shortly thereafter, its new sterility testing suite was conditionally approved, making the lab one of the first major components to come online in the expansion. The full manufacturing expansion is expected to be operational in late 2027.
NanoXplore Announces the Creation of an Advisory Board for Its Subsidiary VoltaXplore and Appoints Galvion Founder and Executive Chairman Jonathan Blanshay as Inaugural Member
MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore” or the “Company”) (TSX: GRA and OTCQX: NNXPF) today announced that its wholly owned subsidiary, VoltaXplore Inc. (“VoltaXplore”), has created an Advisory Board to provide strategic guidance as it advances its battery manufacturing strategy, and has appointed Mr. Jonathan Blanshay, founder and Chief Executive Officer of Galvion Inc., as its first member. Galvion Inc. is a global defence company that designs, develops and de
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
Partnership intended to establish a Texas-based manufacturing pathway for pharmaceutical-grade ibogaine as TIRC advances its planned U.S. development program HIGHLIGHTS Texas Ibogaine Research Corporation (“TIRC”), the wholly-owned Texas subsidiary of Psyence BioMed, enters manufacturing partnership with Benuvia Operations, LLC for the planned U.S. manufacture of pharmaceutical-grade ibogaine active pharmaceutical ingredient (“API”) Benuvia operates an 83,000-square-foot, DEA-registered controll
GAC Exports 197,000 Vehicles in Jan-Sep, Marking Nine Consecutive Months of Year-on-Year Doubling
GUANGZHOU, China , Oct. 5, 2026 -- In September, GAC s own-brand exports reached 25,693 units, up 160.9% year-on-year, marking 9 consecutive months of over 100% growth. Cumulative exports from January to September reached 197,701 units, up 138.9%, reaching 156.7% of last year s full-year total and charging toward the annual target of 300,000 units. Asia-Pacific: Localization Efforts Reach New Heights, Brand Building Achieves Breakthroughs In September, Southeast Asian sales rose 32% year-on-year, with Laos up 433%, the Philippines up 301%, and Indonesia up 79%. In Hong Kong SAR, the E9 PHEV reclaimed No.1 in MPV sales in August. On September 17, GAC s Cambodia KD plant launched, marking a shift from complete vehicle exports to local manufacturing. GAC won the 2026 Philippine Automotive Industry Breakthrough Brand Award. On September 20, Myanmar s First Vice President Nyo Saw visited GAC. The GAC GN8 served as the official vehicle for the APEC SME Ministerial Meeting and the 2026 Fortune Global 500 Forum.
FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
Approval enables AVT02 drug substance for U.S. commercial supply to be manufactured in either of Alvotech’s two Reykjavik drug substance suites Further confirms resolution of FDA inspection-related matters at the Reykjavik site REYKJAVIK, Iceland (October 5, 2026) - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has ap
FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
Approval enables AVT02 drug substance for U.S. commercial supply to be manufactured in either of Alvotech’s two Reykjavik drug substance suites Further confirms resolution of FDA inspection-related matters at the Reykjavik site REYKJAVIK, Iceland, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administrati
VB Health Launches Public Seven-Part Supplement Quality Standard
New company-wide standard, effective across the VB Health portfolio, establishes requirements for research, clinically relevant dosing, formula transparency, sourcing, U.S. manufacturing and every-batch testing DENVER, Oct. 03, 2026 (GLOBE NEWSWIRE) -- VB Health, a Denver-based dietary supplement company co-founded by a U.S.-licensed physician, launched the VB Health Supplement Quality Standard today, a new public seven-part framework that establishes company-wide requirements for how its supple
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
SpyGlass Pharma acquires 100% of the outstanding shares of AVS, a subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), the existing manufacturer of SpyGlass Pharma’s intraocular lens (IOL) Secures scalable commercial IOL manufacturing capacity for its Phase 3 lead product candidate, the BIM-IOL System Accelerates pathway to adding premium lens options into its IOL-based drug delivery system SpyGlass Pharma intends to continue supporting AVS customers and licensees utilizing their proprietary
J.K. Fenner (India) Limited Announce Strategic Relationship with Yamada Manufacturing Co., Ltd.
CHENNAI, India , Oct. 1, 2026 -- J.K. Fenner (India) Limited, a leading manufacturer of automotive and industrial engineering solutions, today announced a strategic relationship with Yamada Manufacturing Co., Ltd., Japan, to strengthen the development and manufacturing of advanced automotive components for domestic and global markets. Established in 1946, Yamada Manufacturing Co., Ltd., Japan, is a leading Japanese automotive component manufacturer with expertise in oil pumps, water pumps, steering columns, drivetrain components, and other precision automotive systems. The company serves leading global OEMs, bringing decades of engineering excellence and manufacturing expertise.
TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness
Serge Rogasik TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness TAPI Steroid manufacturing TAPI Steroid manufacturing TEL AVIV, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- TAPI (Technology & API Services) today announced the appointment of Serge Rogasik as its Chief Executive Officer. Mr. Rogasik will lead a global business that combines a broad API portfolio, deep scientific and technical capabilities, and an extensive global operations n
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal s dedicated sterile injectable facility in Lexington, Kentucky. This partnership addresses ongoing cyclophosphamide shortages and supply chain risks, safeguarding access to this critical medicine for patients across the U.S. MUMBAI, India , Sept. 30, 2026 -- Piramal Pharma Solutions ( PPS ), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. ( PPL ) (NSE: PPLPHARMA) (BSE: 543635), and its partner NP2, a nonprofit generic drug manufacturer, today announced their plans to finish the drug development phase of the generic cancer drug cyclophosphamide in October.
Hawkins, Inc. Expands into Texas’ Dallas–Fort Worth Region with Acquisition of Eagle Labs, Inc.
ROSEVILLE, Minn., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of the assets of Eagle Labs, Inc. (“Eagle Labs”). Eagle Labs distributes water treatment products directly to customers in Texas from its operations in the Dallas–Fort Worth region and has in-house manufacturing capabilities. “The acquisition of Eagle Labs extends our reach into the Dallas–Fort Worth region and continues our
Carbios and the Fiber-to-Fiber Consortium successfully validate the industrial-scale production of recycled polyester T-shirts made from complex plastic and textile waste.
Production of high-performance recycled polyester T-shirts enabled by Carbios’ technology Full validation across the textile value chain, from pre-industrial recycling to industrial-scale manufacturing Identical performance between EnzyTex 1 recycled polyester and virgin polyester Three years of collaboration demonstrating the performance of fiber-to-fiber enzymatic recycling at scale Clermont-Ferrand (France), 29 September 2026 (7:45 am CEST). Carbios (Euronext Growth Paris: ALCRB) announces th
Segway Powersports Brings Latin American and Canadian Media and Creators from Factory Floor to Real-World Terrain
CHANGZHOU, China , Sept. 29, 2026 -- Segway Powersports hosted 14 media representatives and creators from Canada, Chile, Peru, Panama, Brazil and Argentina from September 14 19 for the SEGWAY POWERSPORTS CHINA TOUR-2026 LATAM & CANADA EDITION , an immersive program connecting behind-the-scenes manufacturing insights with a full-lineup off-road riding experience. The program began at Segway Powersports manufacturing facility in Changzhou, China, where participants explored production, assembly, vehicle testing and final inspection. The visit offered a closer look at the manufacturing processes, quality controls and traceability practices behind Segway Powersports vehicles.
GAC Quark Electric Drive Technology Wins Top Honor at Geneva Inventions Exhibition
GUANGZHOU, China , Sept. 25, 2026 -- The results of the 51st International Exhibition of Inventions Geneva have been announced. The project Key Precision Manufacturing Technologies and Applications for Low-Loss Stator Cores Based on Ultra-Thin Amorphous Materials, co-developed with GAC Group, received the exhibition s highest distinction, the Gold Medal with the Congratulations of the Jury. The award is selected from Gold Medal winners and requires unanimous approval from the jury.
Ritedose Positioned to Support Hospitals with Reliable and Quality Albuterol Inhalation Solution, USP 0.5% (Albuterol Concentrate) Supply
Ritedose expands albuterol inhalation solution production and strengthens its role as a trusted source for inhaled solutions The Company ramped up multiple albuterol inhalation solution strengths during national shortage, reinforcing its role as a trusted source for inhaled solutions COLUMBIA, S.C., Sept. 24, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation expanded production of multiple albuterol inhalation solution strengths and invested in additional respiratory manufacturing capabilities d
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
Plan combines up to $25 million in new capital with restructuring of $3 million in existing debt to support commercial execution and manufacturing expansion Company anticipates positive monthly operating cash flow by the end of Q1 2027 Philip A. Barach to join the Board, bringing financial expertise and a focus on capital discipline FLORHAM PARK, N.J., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company,
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
Heidelberg site to lead GMP development of lactoperoxidase and glucose oxidase for Phase II clinical trials AGC Biologics Heidelberg site Microbial projects are underway at AGC Biologics’ Heidelberg facility. HEIDELBERG, Germany, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Belgian biopharmaceutical company Flen Health has selected AGC Biologics as their CDMO partner to provide process development, scale-up, and GMP manufacturing services for a new and improved wound and skin healing product. Manufacturin
Nexteer Opens New Liuzhou Plant, Advancing Smart Manufacturing and Supply Chain Collaboration
LIUZHOU, China , Sept. 24, 2026 / PRNewswire / -- Nexteer Automotive ( Liuzhou ) Co., Ltd. officially opened its new plant today. Since establishing operations in Liuzhou in 2015, Nexteer has continued to strengthen its local presence, producing more than 12 million steering system units at its Liuzhou operations. To further meet growing demand from domestic and global customers and support continued expansion into overseas markets such as Southeast Asia, the opening of the new plant represents a comprehensive upgrade of Nexteer s smart manufacturing and supply chain collaboration capabilities, bringing new momentum into the high-quality development of the regional automotive industry.
CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care ROCHESTER, N.Y. , Sept. 23, 2026 -- CooperVision today unveiled the grand opening of The Vision Centre, the company s new global innovation hub in Southampton, England, and announced six major product advancements that have been accelerated to launch over the next several years. The announcements were made as CooperVision brings together research and development, clinical expertise, pilot manufacturing, advanced technologies, and commercial capabilities to accelerate the development and commercialization of breakthrough solutions for patients and eye care professionals worldwide.
Hughes Precision Raises ₹250+ Crore to Accelerate Ammunition Manufacturing Expansion
Goa-based defence manufacturer to establish medium-caliber ammunition manufacturing capability PANAJI, India , Sept. 23, 2026 -- Hughes Precision Manufacturing Pvt. Ltd., one of India s growing private-sector ammunition manufacturers, has completed an investment round of 250+ crore through a combination of primary and secondary investment from a group of marquee ultra-high-net-worth individuals (UHNIs). The investment will support the Company s next phase of growth, including the expansion of its existing small-caliber ammunition manufacturing capacity from approximately 80 million rounds to 220 million rounds and the establishment of a dedicated medium-caliber ammunition manufacturing facility .
Pylontech Starts Mass Production of 588Ah and 601Ah LFP Cells for ESS
HEFEI, China , Sept. 22, 2026 -- Pylontech (688063:SH) starts mass production of its 588Ah and 601Ah Prismatic LFP Cells for ESS at its Hefei manufacturing base on September 21, marking a new step in the company s expansion into utility-scale energy storage. Developed in-house, the 588Ah and 601Ah cells are designed for large-scale energy storage applications, offering high safety, long cycle life and high energy efficiency. More than 100MWh of the new cells have already been produced , demonstrating the company s ability to manufacture the new products at scale. The cells are also being integrated into Pylontech s next-generation PyOcean 6.25MWh and 8MWh energy storage systems , which are set to enter project delivery.
CATL kicks off trial production of battery cells in Hungary
DEBRECEN, Hungary , Sept. 22, 2026 -- CATL begins trial production on 22 September 2026 in its newly built cell factory in Debrecen as the company had fulfilled all preconditions required to commence trial run. The purpose of trial production is to set up, optimise and validate the production equipment and manufacturing processes ahead of the start of series production. CATL Debrecen continues cooperating and working closely with the government and the authorities in order to keep high standards on the environmental issues as well as the health and safety of its employees.
Abivax Presents Business Updates and First Half 2026 Financial Results
Abivax Presents Business Updates and First Half 2026 Financial Results Chris Rabbat to succeed Fabio Cataldi as Chief Medical Officer; Tim Kelly appointed Chief Technical Officer to advance commercial supply readiness and lead Abivax’s Chemistry, Manufacturing and Controls (“CMC”), Quality and Information Technology (“IT”) functions Cash, cash equivalents and short-term investments of €402.4 million as of June 30, 2026, combined with €767.1 million in net proceeds from the early July underwritte
Highlights to be presented at Novo’s Capital Markets Day 2026
Bagsværd, Denmark, 21 September 2026 – Novo Nordisk is today hosting a Capital Markets Day (CMD) in London, where the company is providing an update to its Corporate strategy and strategic ambitions for 2030 1 . During the day, Novo senior management presentations will cover Corporate strategy, R&D strategy, where to play and how to win across therapy areas, Commercial strategy in the US and International Operations, Global Manufacturing & Supply and Financials. Key highlights of the strategic a
GAC Cambodia KD Plant Starts Production, Setting a New Benchmark for Localized Manufacturing
KAMPONG CHHNANG, Cambodia , Sept. 19, 2026 -- On September 17, the inauguration ceremony of GAC Cambodia KD Plant was grandly held in Kampong Chhnang Province. Cambodian Prime Minister Hun Manet and Chinese Ambassador to Cambodia Wang Wenbin attended the ceremony, while Jiang Xiuyun, Deputy General Manager of GAC Group, and Wang Shunsheng, Deputy General Manager of GAC International and President of the Southeast Asia Regional Center, together with the leadership of TH Group, GAC s strategic partner in Cambodia, witnessed the official launch of the THAM assembly plant for GAC vehicles. This marks a new stage in GAC s development in Cambodia, transitioning from complete vehicle exports to local manufacturing, and stands as yet another achievement of China-Cambodia economic and trade cooperation.
GAC Cambodia KD Plant Starts Production, Setting a New Benchmark for Localized Manufacturing
Cambodia , Sept. 19, 2026 -- On September 17, the inauguration ceremony of GAC Cambodia KD Plant was grandly held in Kampong Chhnang Province. Cambodian Prime Minister Hun Manet and Chinese Ambassador to Cambodia Wang Wenbin attended the ceremony, while Jiang Xiuyun, Deputy General Manager of GAC Group, and Wang Shunsheng, Deputy General Manager of GAC International and President of the Southeast Asia Regional Center, together with the leadership of TH Group, GAC s strategic partner in Cambodia, witnessed the official launch of the THAM assembly plant for GAC vehicles. This marks a new stage in GAC s development in Cambodia, transitioning from complete vehicle exports to local manufacturing, and stands as yet another achievement of China-Cambodia economic and trade cooperation.
NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update
CEO Dr. Lior Shaltiel and R&D Director Dr. Tali Kizhner to engage with industry, investors and scientific leaders during a concentrated week in Boston TORONTO and HAIFA, Israel, Sept. 18, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biotechnology company developing exosome-based regenerative therapies, today announced a series of U.S. engagements across four major life sciences events taking place in Boston from Septem
XCMG Breaks Ground on Its First Overseas Base for Mining Equipment Component Overhaul and Remanufacturing in Indonesia
BALIKPAPAN, Indonesia , Sept. 18, 2026 -- XCMG broke ground on the XCMG Indonesia Remanufacturing Center on Sept. 16 in Balikpapan, Indonesia. As XCMG s first overseas base dedicated to the overhaul and remanufacturing of mining equipment components, the project marks the start of a localized aftermarket service center supporting equipment throughout its operational lifecycle and represents a key step in the company s overseas localization strategy.
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
The center will be a hub for Roche and Genentech, bringing together expertise in Cardiovascular, Renal and Metabolism, as well as for data science and AI specialists to drive innovation in drug discovery and development It will expand Roche’s and Genentech’s presence in Boston, reflecting a long-term commitment to one of the world’s leading life sciences hubs This is part of Roche and Genentech’s USD 50 billion investment in US manufacturing and R&D, building on recent investments and manufactur